scherichia albertii is an emerging human enteric pathogen (1). It belongs to the attaching and effacing group of bacteria, which also includes enteropathogenic and Shiga toxin-producing Escherichia coli (EPEC and STEC, respectively). Shiga toxin-producing E. albertii has been described, however, only in association with Shiga toxin (stx) subtype 2f (2). Sporadic infections as well as foodborne outbreaks caused by E. albertii have been reported, although rarely (3, 4). The prevalence, epidemiology, and clinical relevance of E. albertii are poorly understood, probably due to underestimation and misclassification of this pathogen (4). The phenotypic features distinguishing E. albertii from E. coli include a negative indole reaction and an inability to ferment lactose-, Dsorbitol, and D-xylose (1).
2014 (n ϭ 39) were examined for the presence of stx 2f (8) and the cytolethal distending toxin B gene (cdtB) (9) .
Interestingly, the E. albertii isolate identified in the present study carried stx 2a , hitherto never reported in E. albertii. Additionally, we showed that stx 2a was expressed. This indicates that E. albertii is able to transduce not only stx 2f -carrying bacteriophages but also stx 2a -carrying bacteriophages. STEC harboring eae and stx 2a are considered highly virulent and have the ability to induce life-threatening hemolytic uremic syndrome (HUS) in infected patients (10) . In contrast, STEC harboring stx 2f are associated with milder symptoms (11) and have, to our knowledge, never previously been detected in HUS patients. The patient infected with stx 2a -positive E. albertii was 48 years old, had bloody diarrhea, and was infected in Norway (Table 1) . Domestically acquired E. albertii infection was commonly seen in patients included in the present study; however, the majority of the patients were young (Յ5 years) and did not have bloody stools. In addition to carrying eae, all isolates harbored cdtB, a cyclomodulin and genotoxin gene also common in sorbitol-fermenting O157 STEC strains, bacteria leading to HUS in up to 50% of infected patients (12) . stx 2f was (6) . cdt-1 detects the cytolethal distending toxin B (cdtB) subtypes II, III, and V, whereas cdt-2 detects the cdtB subtypes I and IV. present in 10% (4/39) of the E. albertii isolates, a finding comparable with those of previous studies (4) ( Table 1) . Thus, E. albertii has the ability to carry virulence characteristics, including stx 2a , that are associated with severe illness in infected patients. Therefore, an increased awareness of this underestimated and misidentified pathogen is important.
